Alpine Immune Science Inc on Breakout watch $alpn
Technically setting up for breakout.
200ma may be break.
Downtrend approaching.
RSI just crossed mid point.
MACD reversing off Zero line as Histogram ticks higher
Average analysts price target $11 ! Buy
Company profile
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company. The firm engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.
200ma may be break.
Downtrend approaching.
RSI just crossed mid point.
MACD reversing off Zero line as Histogram ticks higher
Average analysts price target $11 ! Buy
Company profile
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company. The firm engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.